{"id":"https://openalex.org/W4367305156","doi":"https://doi.org/10.1212/wnl.0000000000201746","title":"Overview of the Safety Profile from Efgartigimod Clinical Trials in Participants with Diverse IgG-Mediated Autoimmune Diseases (P1-5.001)","display_name":"Overview of the Safety Profile from Efgartigimod Clinical Trials in Participants with Diverse IgG-Mediated Autoimmune Diseases (P1-5.001)","publication_year":2023,"publication_date":"2023-04-25","ids":{"openalex":"https://openalex.org/W4367305156","doi":"https://doi.org/10.1212/wnl.0000000000201746"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.0000000000201746","doi":"https://doi.org/10.1212/wnl.0000000000201746","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000201746","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032958952","display_name":"Kelly Graham Gwathmey","orcid":"https://orcid.org/0000-0002-7589-8826","observed_orcids":["https://orcid.org/0000-0002-7589-8826"]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly Gwathmey","raw_affiliation_strings":["Department of Neurology, Virginia Commonwealth University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Virginia Commonwealth University","institution_ids":["https://openalex.org/I184840846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031024904","display_name":"Catherine M. Broome","orcid":"https://orcid.org/0000-0003-1507-2851","observed_orcids":["https://orcid.org/0000-0003-1507-2851"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine Broome","raw_affiliation_strings":["Department of Medicine, Georgetown University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Georgetown University","institution_ids":["https://openalex.org/I184565670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076078511","display_name":"Matthias Goebeler","orcid":"https://orcid.org/0000-0001-7095-9848","observed_orcids":["https://orcid.org/0000-0001-7095-9848"]},"institutions":[{"id":"https://openalex.org/I4210126310","display_name":"Universit\u00e4tsklinikum W\u00fcrzburg","ror":"https://ror.org/03pvr2g57","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210126310"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Matthias Goebeler","raw_affiliation_strings":["Department of Dermatology, Venereology and Allergology, University Hospital W\u00fcrzburg"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Venereology and Allergology, University Hospital W\u00fcrzburg","institution_ids":["https://openalex.org/I4210126310"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077281690","display_name":"Hiroyuki Murai","orcid":"https://orcid.org/0000-0003-1612-1440","observed_orcids":["https://orcid.org/0000-0003-1612-1440"]},"institutions":[{"id":"https://openalex.org/I79072001","display_name":"International University of Health and Welfare","ror":"https://ror.org/053d3tv41","country_code":"JP","type":"education","lineage":["https://openalex.org/I79072001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroyuki Murai","raw_affiliation_strings":["Department of Neurology, School of Medicine, International University of Health and Welfare"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, School of Medicine, International University of Health and Welfare","institution_ids":["https://openalex.org/I79072001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070831366","display_name":"Zsuzsanna Bata\u2010Cs\u00f6rg\u00f5","orcid":"https://orcid.org/0000-0002-3732-1743","observed_orcids":["https://orcid.org/0000-0002-3732-1743"]},"institutions":[{"id":"https://openalex.org/I227486990","display_name":"University of Szeged","ror":"https://ror.org/01pnej532","country_code":"HU","type":"education","lineage":["https://openalex.org/I227486990"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Zsuzsanna Bata-Csorgo","raw_affiliation_strings":["Department of Dermatology and Allergology, University of Szeged"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology and Allergology, University of Szeged","institution_ids":["https://openalex.org/I227486990"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011059993","display_name":"Adrian C. Newland","orcid":"https://orcid.org/0000-0003-1079-9496","observed_orcids":["https://orcid.org/0000-0003-1079-9496"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Adrian Newland","raw_affiliation_strings":["Centre for Haematology, Barts and the London School of Medicine & Dentistry, Queen Mary University of London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Haematology, Barts and the London School of Medicine & Dentistry, Queen Mary University of London","institution_ids":["https://openalex.org/I166337079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029827503","display_name":"Peter Ulrichts","orcid":"https://orcid.org/0000-0002-2560-2732","observed_orcids":["https://orcid.org/0000-0002-2560-2732"]},"institutions":[{"id":"https://openalex.org/I4210157284","display_name":"Argenx (Belgium)","ror":"https://ror.org/04spfxf63","country_code":"BE","type":"company","lineage":["https://openalex.org/I4210157284"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Peter Ulrichts","raw_affiliation_strings":["argenx"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"argenx","institution_ids":["https://openalex.org/I4210157284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021687109","display_name":"Ren\u00e9 Kerstens","orcid":"https://orcid.org/0000-0001-6022-109X","observed_orcids":["https://orcid.org/0000-0001-6022-109X"]},"institutions":[{"id":"https://openalex.org/I4210157284","display_name":"Argenx (Belgium)","ror":"https://ror.org/04spfxf63","country_code":"BE","type":"company","lineage":["https://openalex.org/I4210157284"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Rene Kerstens","raw_affiliation_strings":["argenx"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"argenx","institution_ids":["https://openalex.org/I4210157284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049165680","display_name":"Jeffrey T. Guptill","orcid":"https://orcid.org/0000-0002-0312-0716","observed_orcids":["https://orcid.org/0000-0002-0312-0716"]},"institutions":[{"id":"https://openalex.org/I4210157284","display_name":"Argenx (Belgium)","ror":"https://ror.org/04spfxf63","country_code":"BE","type":"company","lineage":["https://openalex.org/I4210157284"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jeffrey Guptill","raw_affiliation_strings":["argenx"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"argenx","institution_ids":["https://openalex.org/I4210157284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082717610","display_name":"Sofiane Agha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157284","display_name":"Argenx (Belgium)","ror":"https://ror.org/04spfxf63","country_code":"BE","type":"company","lineage":["https://openalex.org/I4210157284"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Sofiane Agha","raw_affiliation_strings":["argenx"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"argenx","institution_ids":["https://openalex.org/I4210157284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100774351","display_name":"Ming Jiang","orcid":"https://orcid.org/0000-0002-7259-4165","observed_orcids":["https://orcid.org/0000-0002-7259-4165"]},"institutions":[{"id":"https://openalex.org/I4210157284","display_name":"Argenx (Belgium)","ror":"https://ror.org/04spfxf63","country_code":"BE","type":"company","lineage":["https://openalex.org/I4210157284"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Ming Jiang","raw_affiliation_strings":["argenx"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"argenx","institution_ids":["https://openalex.org/I4210157284"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036542525","display_name":"James F. Howard","orcid":"https://orcid.org/0000-0002-7136-8617","observed_orcids":["https://orcid.org/0000-0002-7136-8617"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Howard","raw_affiliation_strings":["Department of Neurology, The University of North Carolina at Chapel Hill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, The University of North Carolina at Chapel Hill","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1653,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.41337025,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":94},"biblio":{"volume":"100","issue":"17_supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.5590999722480774,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.5590999722480774,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","score":0.25,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.028300000354647636,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/efgartigimod","display_name":"efgartigimod","score":0.9869999885559082},{"id":"https://openalex.org/keywords/generalized-myasthenia-gravis","display_name":"generalized myasthenia gravis","score":0.9580000042915344},{"id":"https://openalex.org/keywords/primary-immune-thrombocytopenia","display_name":"primary immune thrombocytopenia","score":0.9259999990463257},{"id":"https://openalex.org/keywords/pemphigus-vulgaris","display_name":"pemphigus vulgaris","score":0.921999990940094},{"id":"https://openalex.org/keywords/pemphigus-foliaceus","display_name":"pemphigus foliaceus","score":0.9950000047683716},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8029999732971191},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7670000195503235},{"id":"https://openalex.org/keywords/adapt-trial","display_name":"ADAPT trial","score":0.5699999928474426},{"id":"https://openalex.org/keywords/advance-trial","display_name":"ADVANCE trial","score":0.9900000095367432}],"concepts":[{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7656970620155334},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7061389684677124},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.694610059261322},{"id":"https://openalex.org/C2781313415","wikidata":"https://www.wikidata.org/wiki/Q3899001","display_name":"Pemphigus vulgaris","level":2,"score":0.6755430698394775},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6608724594116211},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.659082293510437},{"id":"https://openalex.org/C2781327288","wikidata":"https://www.wikidata.org/wiki/Q1483214","display_name":"Pemphigus","level":2,"score":0.5995345711708069},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.45718997716903687},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45675429701805115},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4437515437602997},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.44105178117752075},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.43352025747299194},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3887195587158203},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35812634229660034},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.055952101945877075},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.0000000000201746","doi":"https://doi.org/10.1212/wnl.0000000000201746","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000201746","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8799999952316284}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4394600003","https://openalex.org/W4390904672","https://openalex.org/W4379279894","https://openalex.org/W4366172066","https://openalex.org/W4409903417","https://openalex.org/W4390260741","https://openalex.org/W3206157949","https://openalex.org/W4416996889","https://openalex.org/W6967308790","https://openalex.org/W2944937742"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"assess":[2],"the":[3,23,170,283,302,320,338,356,374,399,419,443,467,491,559,580,598,622,641,660,690,709,728,746,764,798,842,861,879,898,925,965,996,1020,1044,1068,1153,1200,1225,1250,1275,1299,1327,1354,1379],"safety":[4,64,146],"profile":[5],"of":[6,41,120,167,209,285,304,322,340,358,376,401,421,445,469,493,510,521,532,543,561,572,582,600,624,643,662,674,692,711,730,748,766,779,800,812,844,863,881,900,927,950,967,987,998,1022,1046,1070,1093,1104,1115,1126,1137,1155,1177,1190,1202,1227,1252,1277,1301,1329,1356,1381,1420,1430,1442,1454,1469,1480,1496,1509,1521,1549],"efgartigimod":[7,50,63,142,197,230],"across":[8,177,194,251],"different":[9,115],"IgG-mediated":[10,57],"disorders.":[11,59],"Background:":[12],"Efgartigimod":[13,213,235,247],"is":[14,51,248,1552,1577],"a":[15,52,80,91,144,290,309,327,345,363,381,406,426,450,474,498,566,587,605,629,648,667,697,716,735,753,771,805,829,849,868,886,932,972,1003,1027,1051,1075,1160,1207,1232,1257,1282,1306,1334,1361,1386,1534,1538,1562,1566],"first-in-class,":[16],"human":[17],"IgG":[18,31,45],"Fc":[19,25],"fragment":[20],"that":[21,1551,1576],"inhibits":[22],"neonatal":[24],"receptor":[26],"(FcRn)":[27],"and":[28,38,79,101,110,127,133,139,207,253,266,916,1573],"outcompetes":[29],"endogenous":[30],"binding.":[32],"This":[33],"results":[34],"in":[35,67,72,90,96,107,125,131,169,183,200,205,217,222,264,270,282,301,319,337,355,373,398,418,442,466,490,558,579,597,621,640,659,689,708,727,745,763,797,841,860,878,897,924,956,964,995,1019,1043,1067,1089,1152,1199,1224,1249,1274,1298,1326,1353,1378,1396,1404,1413,1425],"reduced":[36],"recycling":[37],"increased":[39],"degradation":[40],"IgGs,":[42],"including":[43,122,258],"pathogenic":[44],"autoantibodies.":[46],"FcRn":[47],"inhibition":[48],"by":[49],"rational":[53],"therapeutic":[54],"option":[55],"for":[56,287,292,306,311,324,329,342,347,360,365,378,389,403,409,423,434,447,458,471,482,495,506,563,568,584,589,602,613,626,632,645,651,664,670,694,713,718,732,737,750,755,768,774,802,807,846,851,865,870,883,888,902,914,929,945,969,974,982,1000,1011,1024,1035,1048,1059,1072,1083,1157,1172,1185,1204,1215,1229,1240,1254,1265,1279,1290,1303,1314,1331,1342,1358,1369,1383,1389,1489],"autoimmune":[58],"Design/Methods:":[60],"Intravenous":[61],"(IV)":[62],"was":[65,87,214],"assessed":[66],"generalized":[68],"myasthenia":[69],"gravis":[70],"(gMG)":[71],"phase":[73,75,92,104],"2,":[74],"3":[76,93],"(ADAPT)":[77],"trials,":[78],"3-year":[81],"open-label":[82,103],"extension":[83],"(ADAPT+)":[84],"trial.":[85],"It":[86],"also":[88],"evaluated":[89],"trial":[94,106],"(ADVANCE)":[95],"primary":[97],"immune":[98],"thrombocytopenia":[99],"(ITP)":[100],"an":[102,905,948,985,1175,1188],"2":[105],"pemphigus":[108,173,210],"(vulgaris":[109],"foliaceus).":[111],"These":[112],"studies":[113,178,195],"examined":[114],"dosing":[116,124,130],"regimens":[117],"(10\u201325":[118],"mg/kg)":[119],"efgartigimod,":[121],"cyclical":[123],"gMG":[126],"continuous":[128],"weekly":[129],"ITP":[132],"pemphigus.":[134],"Results:":[135],"Across":[136],"all":[137],"indications":[138,252],"doses":[140,254],"studied,":[141],"demonstrated":[143],"consistent":[145],"profile,":[147],"with":[148,219,228,272,700,936,1164,1545,1569],"comparable":[149],"treatment":[150,236],"emergent":[151],"adverse":[152,189],"event":[153],"(TEAE)":[154],"rates":[155,186,225],"to":[156,181,188,233,832,1554,1579],"placebo":[157,199,204],"(ADAPT":[158],"77.4%":[159],"efgartigimod/84.3%":[160],"placebo;":[161,165],"ADVANCE":[162],"93.0%":[163],"efgartigimod/95.6%":[164],"85%":[166],"participants":[168],"open":[171],"label":[172],"study).":[174],"Most":[175,256],"TEAEs":[176],"were":[179,191,260],"mild":[180,261],"moderate":[182,263],"severity.":[184],"Discontinuation":[185],"due":[187],"events":[190],"consistently":[192],"low":[193],"(3.6%":[196],"group/3.6%":[198],"ADAPT;":[201],"3.5%":[202],"efgartigimod/2.2%":[203],"ADVANCE;":[206],"3%":[208],"study":[211],"participants).":[212],"well":[215,249],"tolerated":[216,250],"ADAPT+,":[218],"no":[220],"increase":[221,243,269],"TEAE":[223],"incidence":[224],"or":[226,242,262,384,429,453,477,501,608,909,1006,1030,1054,1078,1210,1235,1260,1285,1309,1337,1364,1557,1582],"infections":[227],"repeated":[229],"cycles":[231],"(up":[232],"19).":[234],"did":[237,267],"not":[238,268],"reduce":[239],"albumin":[240],"levels":[241],"cholesterol":[244],"levels.":[245],"Conclusions:":[246],"studied.":[255],"TEAEs,":[257],"infections,":[259],"severity":[265],"frequency":[271],"recurrent":[273],"dosing.":[274],"Disclosure:":[275],"Dr.":[276,295,313,331,349,367,392,412,436,460,484,511,522,533,544,702,721,739,757,780,976,989,1013,1037,1061,1085,1094,1105,1116,1127,1138,1146,1166,1193,1218,1243,1268,1292,1320,1347,1372,1392,1400,1409,1421,1431,1443,1455,1470,1481,1497,1510,1522,1531,1559],"Gwathmey":[277,296,314,332,350,368,393],"has":[278,297,315,333,351,369,394,414,438,462,486,513,524,535,546,554,575,593,617,636,655,677,685,704,723,741,759,782,793,815,824,837,856,874,893,920,941,954,960,978,991,1015,1039,1063,1087,1096,1107,1118,1129,1140,1148,1168,1181,1195,1220,1245,1270,1294,1322,1349,1374,1394,1402,1411,1423,1433,1445,1457,1472,1483,1499,1512,1524,1533,1561],"received":[279,298,316,334,352,370,395,415,439,463,487,514,525,536,547,555,576,594,618,637,656,678,686,705,724,742,760,783,794,816,825,838,857,875,894,921,942,961,979,992,1016,1040,1064,1097,1108,1119,1130,1141,1149,1169,1182,1196,1221,1246,1271,1295,1323,1350,1375,1434,1446,1458,1473,1484,1500,1513,1525],"personal":[280,299,317,335,353,371,396,416,440,464,488,556,577,595,619,638,657,687,706,725,743,761,795,839,858,876,895,922,943,962,980,993,1017,1041,1065,1150,1170,1183,1197,1222,1247,1272,1296,1324,1351,1376],"compensation":[281,300,318,336,354,372,397,417,441,465,489,557,578,596,620,639,658,688,707,726,744,762,796,840,859,877,896,923,944,963,981,994,1018,1042,1066,1151,1171,1184,1198,1223,1248,1273,1297,1325,1352,1377],"range":[284,303,321,339,357,375,400,420,444,468,492,560,581,599,623,642,661,691,710,729,747,765,799,843,862,880,899,926,966,997,1021,1045,1069,1154,1201,1226,1251,1276,1300,1328,1355,1380],"$500-$4,999":[286,305,323,341,359,402,494,562,583,601,625,644,663,712,731,749,767,801,845,864,1023,1047,1071,1156,1278,1357],"serving":[288,307,325,343,361,379,404,424,448,472,496,564,585,603,627,646,665,695,714,733,751,769,803,847,866,884,903,930,946,970,983,1001,1025,1049,1073,1158,1173,1186,1205,1230,1255,1280,1304,1332,1359,1384],"as":[289,308,326,344,362,565,586,696,715,734,752,804,848,867,885,904,931,947,971,984,1159,1174,1187,1537,1565],"Consultant":[291,310,328,346,364,567,588,717,736,754,806,850,869,887,973],"Alexion":[293,390,410,719,1266,1438],"Pharmaceuticals.":[294,391,411,720,1242,1267,1439,1518],"Argenx.":[312,330,435,518,590,682,975,1036],"Strongbridge.":[348],"UCB.":[366,701,756],"$5,000-$9,999":[377,901,999,1330],"on":[380,405,425,449,473,497,604,628,647,666,770,1002,1026,1050,1074,1206,1231,1256,1281,1305,1333,1360,1385],"Scientific":[382,427,451,475,499,606,1004,1028,1052,1076,1208,1233,1258,1283,1307,1335,1362,1539],"Advisory":[383,428,452,476,500,607,911,1005,1029,1053,1077,1209,1234,1259,1284,1308,1336,1363],"Data":[385,430,454,478,502,609,1007,1031,1055,1079,1211,1236,1261,1286,1310,1338,1365],"Safety":[386,431,455,479,503,610,1008,1032,1056,1080,1212,1237,1262,1287,1311,1339,1366],"Monitoring":[387,432,456,480,504,611,1009,1033,1057,1081,1213,1238,1263,1288,1312,1340,1367],"board":[388,433,457,481,505,612,1010,1034,1058,1082,1214,1239,1264,1289,1313,1341,1368],"Speakers":[407,630,649,668,772,1387],"Bureau":[408,631,650,669,773,1388],"Broome":[413,437,461,485,512,523,534,545],"$10,000-$49,999":[422,446,470,882,928,1203,1228,1253,1302,1382],"Alexion.":[459,1012],"Sanofi.":[483,529],"Incyte.":[507,540],"The":[508,519,530,541,570,672,777,810,1091,1102,1113,1124,1135,1428,1440,1452,1467,1478,1494,1507,1519],"institution":[509,520,531,542,571,673,778,811,1092,1103,1114,1125,1136,1429,1441,1453,1468,1479,1495,1508,1520],"research":[515,526,537,548,679,784,817,1098,1109,1120,1131,1142,1435,1447,1459,1474,1485,1501,1514,1526],"support":[516,527,538,549,680,785,818,1099,1110,1121,1132,1143,1436,1448,1460,1475,1486,1502,1515,1527],"from":[517,528,539,550,681,786,819,828,1100,1111,1122,1133,1144,1437,1449,1461,1476,1487,1503,1516,1528],"Rigel.":[551],"Prof.":[552,573,591,615,634,653,675,683,791,813,822,835,854,872,891,918],"Goebeler":[553,574,592,616,635,654,676,684],"Almirall.":[569],"GSK.":[614,633],"Janssen.":[652],"Lilly.":[671],"$0-$499":[693],"travel":[698],"expenses":[699],"Murai":[703,722,740,758,781],"argenx.":[738,951,957,988,1090,1178],"Chugai":[775],"Pharmaceutical.":[776],"Japan":[787],"Blood":[788],"Products":[789],"Organization.":[790],"Bata-Csorgo":[792,814,823],"Sanofi-Genzyme":[808],"Hungary.":[809,821],"NKFI":[820],"publishing":[826],"royalties":[827],"publication":[830],"relating":[831],"health":[833],"care.":[834],"Newland":[836,855,873,892,919],"OakHill":[852],"Bio.":[853],"Pfizer.":[871],"Angle":[889],"PLC.":[890],"Editor,":[906,908],"Associate":[907],"Editorial":[910],"Board":[912,935,1541],"Member":[913,1163],"Taylor":[915],"Francis.":[917],"Chair,":[933],"Clinical":[934],"BMI":[937],"Healthcare.":[938],"Peter":[939,952],"Ulrichts":[940,953],"employee":[949,986,1176,1189],"stock":[955,1088,1395,1403,1412,1424],"Mr.":[958],"Kerstens":[959],"$100,000-$499,999":[968],"Guptill":[977,990,1014,1038,1062,1086,1095,1106,1117,1128,1139,1147],"Toleranzia.":[1060],"Takeda.":[1084],"NIH.":[1101,1165,1477],"MGFA.":[1112],"PCORI.":[1123],"Verily.":[1134],"UNC.":[1145],"Study":[1161],"Section":[1162],"Agha":[1167],"Mrs.":[1179],"Jiang":[1180],"argenx":[1191,1450],"BV.":[1192],"Howard":[1194,1219,1244,1269,1293,1321,1348,1373,1393,1401,1410,1422,1432,1444,1456,1471,1482,1498,1511,1523,1532,1560],"arenx":[1216],"BVBA.":[1217,1451],"Regeneron":[1241],"Immunivant.":[1291],"Ra":[1315,1462],"Pharma":[1316,1463],"(now":[1317,1464],"UCB":[1318,1465],"Biosciences).":[1319,1466],"Viela":[1343],"Bio":[1344],"(Horizon":[1345],"Therapeutics).":[1346],"Sanofi":[1370],"US.":[1371],"Academic":[1390],"CME.":[1391],"General":[1397],"Electric":[1398],"dividends.":[1399,1408,1415,1427],"Johnson":[1405,1407],"&":[1406],"Pfizer":[1414],"An":[1416],"immediate":[1417],"family":[1418],"member":[1419,1544,1568],"GlaxoSmithKline":[1426],"Centers":[1488],"Disease":[1490],"Control/Research":[1491],"Triangle":[1492],"Institute.":[1493],"Duke":[1504],"University":[1505],"(DCRI).":[1506],"Millenium":[1517],"Cartestian":[1529],"Therapeutics.":[1530],"non-compensated":[1535,1563],"relationship":[1536,1564],"Advisiory":[1540],"member,":[1542],"Committee":[1543,1567],"Myasthenia":[1546],"Gravis":[1547],"Foundation":[1548],"America":[1550],"relevant":[1553,1578],"AAN":[1555,1580],"interests":[1556,1581],"activities.":[1558,1583],"American":[1570],"Assoc":[1571],"Neuromuscular":[1572],"Electrodiagnostic":[1574],"Medicine":[1575]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2023-04-29T00:00:00"}